Clinical Trials Directory

Trials / Conditions / Metastatic Primary Peritoneal Carcinoma

Metastatic Primary Peritoneal Carcinoma

7 registered clinical trials studyying Metastatic Primary Peritoneal Carcinoma — 1 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingTesting the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
NCT05691504
National Cancer Institute (NCI)Phase 1
RecruitingPhase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Pa
NCT05092373
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingNiraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fa
NCT04673448
University of WashingtonPhase 1
WithdrawnAbexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer
NCT04498520
Pamela MunsterPhase 1
CompletedNivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With
NCT03508570
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingGene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY
NCT02650986
Roswell Park Cancer InstitutePhase 1 / Phase 2
Active Not RecruitingCarboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ova
NCT02627443
National Cancer Institute (NCI)Phase 1